How to buy bimetinib/bemetinib

Binimetinib/Binimetinib is a selective small molecule drug mainly used to treat certain types of melanoma, especially those carrying BRAF V600 mutations. It interferes with the growth and proliferation of tumor cells by inhibiting the MEK enzyme in the MAPK signaling pathway. MEK is a key component in the RAS-RAF-MEK-ERK signaling pathway, which plays an important role in the occurrence and development of many tumors. Therefore, bimetinib can effectively prevent the proliferation of tumor cells, delay the progression of the disease, and improve the survival rate of patients.

Clinical studies have shown that bimetinib can significantly improve the therapeutic effect when used in combination with other drugs. For example, better efficacy and longer progression-free survival can be achieved when combined with a BRAF inhibitor such as encorafenib. This combination therapy is already approved to treat certain types of melanoma and has shown good tolerability and efficacy in several clinical trials.

Regarding how to obtain bimetinib, you first need to undergo diagnosis and evaluation through a regular hospital to confirm whether you are suitable for using this drug. Doctors will prescribe prescriptions based on the patient's specific conditions. The original drug Bimetinib is not currently on the market in China, so this drug is not covered by medical insurance. Its price is still unclear. Patients in need can only purchase this drug through relevant overseas channels.

In overseas markets, the European version of bimetinib can be purchased in common packages: 15mg*84 tablets and 15mg*168 tablets, each box is about 20,000 yuan (the price will fluctuate with exchange rate changes). At the same time, the first generic drug of bimetinib has appeared in the overseas market, and its ingredients are close to the original drug. For example, the 15mg*180 tablets produced by Lucius Pharmaceutical Factory in Laos may be sold for more than 6,000 yuan (the price may be adjusted due to exchange rate changes). Because these drugs are usually prescription drugs, patients must follow their doctor's instructions.

Reference materials:https://go.drugbank.com/drugs/DB11967